Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Suanfarma, at the Core of a Better Life.
With Fermion, start the journey of your innovative API.
ASMF
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
Trusted Partner for Innovative, Sustainable, and High-Quality API Development and Production.
Together we can improve the quality of life
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
About the Company : Founded in 1987, Transo-Pharm is a fully licensed and certified global distributor of pharmaceutical components for the health and veterinary industries. The company supports its c...
Suanfarma, at the Core of a Better Life.
About the Company : Suanfarma is a B2B life sciences company dedicated to health and advancement. To achieve this, the company focuses on developing, manufacturing, and distributing high-quality ingre...
With Fermion, start the journey of your innovative API.
About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
About the Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development...
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
About the Company : Kinsy, an independent CDMO in Spain, offers over 30 years of expertise in developing and manufacturing advanced pharmaceutical intermediates and APIs. We provide innovative route d...
Trusted Partner for Innovative, Sustainable, and High-Quality API Development and Production.
About the Company : Alven Laboratories is a pharmaceutical company specializing in the development, scale-up, and production of original and generic Active Pharmaceutical Ingredients (APIs). With expe...
Together we can improve the quality of life
About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with over 26 years of expertise in human and veterinary pharmaceuticals. Operating in 40+ countries, we own two st...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
Lead Product(s) : Levosimendan,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Tenax Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Amendment to the existing agreement gives Tenax rights to develop and commercialize in the United States and Canada an oral formulation of levosimendan for use with Type 2 pulmonary hypertension in heart failure patients with PH-HFpEF, or other heart rel...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 15, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin- 3...
CAS Number : 36725-28-7
End Use API : Levosimendan
About The Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe ...
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(...
CAS Number : 36725-28-7
End Use API : Levosimendan
About The Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
16 Sep 2025
// GLOBENEWSWIRE
05 Mar 2025
// GLOBENEWSWIRE
13 Aug 2024
// GLOBENEWSWIRE
30 Apr 2024
// GLOBENEWSWIRE
09 Apr 2024
// GLOBENEWSWIRE
28 Mar 2024
// GLOBENEWSWIRE
Global Sales Information
Market Place
APIs
Reply
01 Aug 2025
Reply
06 May 2025
Reply
18 Oct 2023
Reply
02 Jun 2020
Reply
04 Feb 2019
Reply
12 Oct 2018
Reply
24 Nov 2015
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
01 Dec 2022
Reply
13 Feb 2021
Reply
22 Jun 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
42
PharmaCompass offers a list of Levosimendan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levosimendan manufacturer or Levosimendan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levosimendan manufacturer or Levosimendan supplier.
PharmaCompass also assists you with knowing the Levosimendan API Price utilized in the formulation of products. Levosimendan API Price is not always fixed or binding as the Levosimendan Price is obtained through a variety of data sources. The Levosimendan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levosimendan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levosimendan, including repackagers and relabelers. The FDA regulates Levosimendan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levosimendan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levosimendan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levosimendan supplier is an individual or a company that provides Levosimendan active pharmaceutical ingredient (API) or Levosimendan finished formulations upon request. The Levosimendan suppliers may include Levosimendan API manufacturers, exporters, distributors and traders.
click here to find a list of Levosimendan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levosimendan DMF (Drug Master File) is a document detailing the whole manufacturing process of Levosimendan active pharmaceutical ingredient (API) in detail. Different forms of Levosimendan DMFs exist exist since differing nations have different regulations, such as Levosimendan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levosimendan DMF submitted to regulatory agencies in the US is known as a USDMF. Levosimendan USDMF includes data on Levosimendan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levosimendan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levosimendan suppliers with USDMF on PharmaCompass.
A Levosimendan written confirmation (Levosimendan WC) is an official document issued by a regulatory agency to a Levosimendan manufacturer, verifying that the manufacturing facility of a Levosimendan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levosimendan APIs or Levosimendan finished pharmaceutical products to another nation, regulatory agencies frequently require a Levosimendan WC (written confirmation) as part of the regulatory process.
click here to find a list of Levosimendan suppliers with Written Confirmation (WC) on PharmaCompass.
Levosimendan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levosimendan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levosimendan GMP manufacturer or Levosimendan GMP API supplier for your needs.
A Levosimendan CoA (Certificate of Analysis) is a formal document that attests to Levosimendan's compliance with Levosimendan specifications and serves as a tool for batch-level quality control.
Levosimendan CoA mostly includes findings from lab analyses of a specific batch. For each Levosimendan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levosimendan may be tested according to a variety of international standards, such as European Pharmacopoeia (Levosimendan EP), Levosimendan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levosimendan USP).
Share 
Comment (4)
